Evidence reviews Treatment of seizures for patients with multiple sclerosis <\/p>\n
Epileptic seizures occur in a relatively small number of patients with multiple sclerosis, but can have serious consequences. Because the cause of epileptic seizures in patients in MS may be different from that in other forms of epilepsy, it is uncertain whether patients with MS should be treated differently. We searched for studies on the treatment of epileptic seizures in patients with MS, but found none. Well designed studies that address this issue are needed. <\/p>\n
Multiple sclerosis (MS) is a chronic disease of the nervous system which affects young and middleaged adults. Repeated damage to parts of the nerves leads to progressive weakness and disability. Hyperbaric oxygen therapy (HBOT) involves people breathing pure oxygen in a specially designed chamber (such as used for deep sea divers suffering pressure problems after resurfacing). HBOT is sometimes used for MS in case a lack of oxygen to the affected nerves may be making MS worse, but this theory is unproven. The review of nine trials found no consistent evidence that HOBT can improve disability or modify the progression of MS. There is little need for further research. <\/p>\n
Multiple sclerosis (MS) is a chronic disease of the nervous system which affects young and middleaged adults. Spasticity, a common problem in people with MS, is a disorder of voluntary movement caused by damage to the central nervous system. The main sign is the resistance to passive movement of a limb but other associated features pain, spasms, loss of function affect people's quality of life more directly. <\/p>\n
See all (305) <\/p>\n
How do disease-modifying drugs compare in multiple sclerosis? <\/p>\n
Dimethyl fumarate (trade name: Tecfidera) has been approved in Germany since January 2014 for adults with relapsing remitting multiple sclerosis. <\/p>\n
Epileptic seizures occur in a relatively small number of patients with multiple sclerosis, but can have serious consequences. Because the cause of epileptic seizures in patients in MS may be different from that in other forms of epilepsy, it is uncertain whether patients with MS should be treated differently. We searched for studies on the treatment of epileptic seizures in patients with MS, but found none. Well designed studies that address this issue are needed. <\/p>\n
See all (72) <\/p>\n
<\/p>\n
Read this article: Evidence reviews Treatment of seizures for patients with multiple sclerosis Epileptic seizures occur in a relatively small number of patients with multiple sclerosis, but can have serious consequences. Because the cause of epileptic seizures in patients in MS may be different from that in other forms of epilepsy, it is uncertain whether patients with MS should be treated differently. We searched for studies on the treatment of epileptic seizures in patients with MS, but found none. Well designed studies that address this issue are needed. Multiple sclerosis (MS) is a chronic disease of the nervous system which affects young and middleaged adults. Repeated damage to parts of the nerves leads to progressive weakness and disability. Hyperbaric oxygen therapy (HBOT) involves people breathing pure oxygen in a specially designed chamber (such as used for deep sea divers suffering pressure problems after resurfacing). HBOT is sometimes used for MS in case a lack of oxygen to the affected nerves may be making MS worse, but this theory is unproven. The review of nine trials found no consistent evidence that HOBT can improve disability or modify the progression of MS. There is little need for further research. Multiple sclerosis (MS) is a chronic disease of the nervous system which affects young and middleaged adults. Spasticity, a common problem in people with MS, is a disorder of voluntary movement caused by damage to the central nervous system. The main sign is the resistance to passive movement of a limb but other associated features pain, spasms, loss of function affect people's quality of life more directly. See all (305) How do disease-modifying drugs compare in multiple sclerosis? Dimethyl fumarate (trade name: Tecfidera) has been approved in Germany since January 2014 for adults with relapsing remitting multiple sclerosis. Epileptic seizures occur in a relatively small number of patients with multiple sclerosis, but can have serious consequences. Because the cause of epileptic seizures in patients in MS may be different from that in other forms of epilepsy, it is uncertain whether patients with MS should be treated differently. We searched for studies on the treatment of epileptic seizures in patients with MS, but found none. Well designed studies that address this issue are needed. See all (72) Continue reading
\nMultiple Sclerosis - National Library of Medicine - PubMed ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"